SpectraScience has placed its Luma cervical imaging system to detect pre-cancers at the University of Iowa in Iowa City.
Subscribe to our email newsletter
SpectraScience’s Luma cervical imaging system was developed to significantly improve the detection of high-grade precancerous cervical abnormalities that have the potential to become invasive cancer.
The Luma system provides a safe and effective method, that when used as an adjunct to colposcopy, has been demonstrated to uncover at least 26% more high-grade precancerous disease than colposcopy alone.
Jim Hitchin, CEO of SpectraScience, said: “We are pleased to have placed our Luma System at the prestigious University of Iowa facility and believe that it is a strong validation of our technology. We are committed to developing and bringing more effective cancer screening technologies to the market with the result of better and earlier diagnosis.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.